Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Syschem (India)BOM:531173 +1.04%57 Days Payable is 75.18 as of Mar. 2026, which is 43% below its 10-year median of 131.98. GuruFocus rates BOM:531173 with a GF Score™ of 57/100 and a GF Value™ of ₹82.33 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 925 Drug Manufacturers companies, Syschem (India) ranks worse than 54.16% on this metric.
The historical rank and industry rank for Syschem (India)'s Days Payable or its related term are showing as below:
BOM:531173'
s Days Payable Range Over the Past 10 Years
Min: 83.15 Med: 131.98 Max: 330.97
Current: 83.15
During the past 13 years, Syschem (India)'s highest Days Payable was 330.97. The lowest was 83.15. And the median was 131.98.
BOM:531173's Days Payable is ranked worse than 54.16% of 925
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs BOM:531173: 83.15
Syschem (India)'s Days Payable
declined
from Mar. 2025 (102.53) to Mar. 2026 (75.18).
It may suggest that Syschem (India)accelerated paying its suppliers.
Syschem (India) Days Payable Related Terms
Syschem (India) Days Payable Historical Data
* Premium members only.
The historical data trend for Syschem (India)'s Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Syschem (India)'s Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syschem (India) Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Syschem (India)'s Days Payable distribution charts can be found below:
* The bar in red indicates where Syschem (India)'s Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Syschem (India)'s Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syschem (India) (BOM:531173) has a Days Payable of 75.18 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Syschem (India) and its competitors. This is 43% below median its historical median of 131.98. Over the past decade, Syschem (India)'s Days Payable has ranged from 83.15 to 330.97. According to the industry distribution chart, Syschem (India) ranks #501 out of 925 companies in the Drug Manufacturers industry, placing it in the top 54.2%.
Is Syschem (India)'s Days Payable too high?
Syschem (India)'s current Days Payable of 75.18 is 43% below median its 10-year median of 131.98. Over the past 10 years, this metric has ranged from a low of 83.15 to a high of 330.97. The Drug Manufacturers industry median Days Payable is 90.38. Syschem (India)'s value of 75.18 is 16.8% below this industry median. Based on the distribution chart, Syschem (India) ranks #501 out of 925 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Syschem (India) has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Syschem (India)'s Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Syschem (India) ranks #501 out of 925 companies for Days Payable. This places Syschem (India) in the lower half of its industry. The industry median Days Payable is 90.38. Syschem (India)'s value of 75.18 is 16.8% below this benchmark. Historically, Syschem (India)'s own Days Payable has ranged from 83.15 to 330.97 over the past decade. While the company's 10-year median is 131.98 vs. the industry median of 90.38, Syschem (India) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Syschem (India)'s current Days Payable of 75.18 is 16.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Syschem (India) and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syschem (India)'s current Days Payable is 75.18, which is 43% below median its own 10-year median of 131.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syschem (India) stock overvalued right now?
Based on GuruFocus' analysis, Syschem (India) (BOM:531173) is currently considered Possible Value Trap. The stock's GF Value™ is ₹82.33, compared to a current price of ₹43.62 — trading 47% below its estimated fair value. The current Days Payable is 75.18, which is 43% below median its 10-year median of 131.98 and 16.8% below the Drug Manufacturers industry median of 90.38. Syschem (India)'s overall GF Score™ is 57/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Syschem (India) (BOM:531173), the current Days Payable is 75.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Syschem (India) (BOM:531173) Overvalued in 2026?
Based on GuruFocus' analysis, Syschem (India) stock appears to be undervalued.
The current stock price of ₹43.62 is trading 47% below its estimated GF Value™ of ₹82.33.
GuruFocus considers Syschem (India) to be Possible Value Trap.
Key valuation signals for BOM:531173:
Days Payable: 75.18 (43% below median its 10-year median of 131.98)
GF Value™: ₹82.33 vs. price of ₹43.62 (47% below fair value)
Industry Position: 16.8% below the Drug Manufacturers median (#501 of 925)
No single metric tells the full story. See the BOM:531173 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Syschem (India) Ltd is a company that produces Active Pharmaceutical Ingredients and bulk drugs. It also undertakes contract manufacturing and custom synthesis business. In addition, the company is also involved in the purification of specialty solvents. The products offered by the company include Amoxycillin Tri-Hydrate, Ampicillin Tri-Hydrate, Cloxacillin Sodium, Dicloxacillin Sodium, Flucloxacillin Sodium, Cephalexin, Cefixime, Cefadroxil, Distillation of Speciality Solvents - DMF, Acetonitrile, Ethyl Acetate, and THF.
57GF Score
Get the complete analysis for BOM:531173
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531173 has been successfully added to your 
